Cite
Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice.
MLA
Xiu-Zhen Li, et al. “Protective Efficacy of Recombinant Canine Adenovirus Type-2 Expressing TgROP18 (CAV-2-ROP18) against Acute and Chronic Toxoplasma Gondii Infection in Mice.” BMC Infectious Diseases, vol. 15, no. 1, Apr. 2015, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12879-015-0815-1.
APA
Xiu-Zhen Li, Xiao-Hu Wang, Li-Jun Xia, Ya-Biao Weng, Jorge A Hernandez, Li-Qing Tu, Lu-Tao Li, Shou-Jun Li, & Zi-Guo Yuan. (2015). Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice. BMC Infectious Diseases, 15(1), 1–10. https://doi.org/10.1186/s12879-015-0815-1
Chicago
Xiu-Zhen Li, Xiao-Hu Wang, Li-Jun Xia, Ya-Biao Weng, Jorge A Hernandez, Li-Qing Tu, Lu-Tao Li, Shou-Jun Li, and Zi-Guo Yuan. 2015. “Protective Efficacy of Recombinant Canine Adenovirus Type-2 Expressing TgROP18 (CAV-2-ROP18) against Acute and Chronic Toxoplasma Gondii Infection in Mice.” BMC Infectious Diseases 15 (1): 1–10. doi:10.1186/s12879-015-0815-1.